Clinical Trials Browser

Extensive Stage Small Cell Lung Cancer × oblimersen × Clear all

NCT00017251 2013-01-24

Combination Chemotherapy Plus Oblimersen in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer

Phase 1 Completed

Extensive Stage Small Cell Lung Cancer